Skip to main content

Table 2 Disease Activity Sub-Groups In Patients Followed Over Three Or More Years

From: Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis

  Always Remission Some Remission No Remission Significance
(n = 68) (n = 376) (n = 308)  
Females (%) 34 (50%) 299 (80%) 246 (80%) P < 0.001*
Caucasian Ethnicity (%) 58 (85%) 287 (76%) 195 (63%) P < 0.001*
Black African/Caribbean Ethnicity (%) 1 (2%) 37 (10%) 62 (20%) P < 0.001*
Initial Mean Age In Years (SD) 54 (16) 55 (15) 56 (14) NS**
Initial Disease Duration In Years (SD) 5 (5) 10 (9) 12 (11) P = 0.003**
Initial Mean DAS28 (SD) 1.65 (0.65) 3.48 (1.32) 4.65 (1.19) P < 0.001**
Overall Mean DAS28 (SD) 1.57 (0.45) 3.06 (0.71) 4.47 (0.82) P < 0.001**
Any Flares (%) 27 (40%) 266 (71%) 194 (63%) P < 0.001*
Overall Mean EQ5D-3 L (SD) 0.77 (0.17) 0.58 (0.24) 0.38 (0.28) P < 0.001**
Initial Mean HAQ (SD) 0.31 (0.50) 1.06 (0.81) 1.58 (0.81) P < 0.001**
Overall Mean HAQ (SD) 0.31 (0.45) 1.03 (0.70) 1.66 (0.67) P < 0.001**
HAQ Below 0.50 On One Or More Occasion (%) 58 (85%) 180 (48%) 56 (18%) P < 0.001*
  1. *Chi-Squared Testing **One Way Analysis Of Variance